Group 1 - The Hang Seng Technology Index opened lower and fluctuated, dropping over 1.5% at one point, and closed down approximately 0.34% at 5349.48 points [1] - The Hang Seng Technology ETF (520570) experienced active trading with a transaction amount of about 115 million yuan and a turnover rate of approximately 4.41%, indicating intense market competition [1] - The ETF saw a net subscription of about 77.85 million yuan yesterday, ranking 17th out of 212 in net inflows among cross-border ETFs, with a cumulative net inflow of approximately 78.75 million yuan over the past five days, reflecting a strong long-term investment interest in the Hong Kong tech sector [1] Group 2 - Analysts believe that the current valuation of the Hong Kong tech sector is at a near five-year low, with the Hang Seng Technology Index showing a historical high in the yield gap compared to the ChiNext Index, indicating a high margin of safety [1] - The Hong Kong tech sector is positioned at the core of AI application and commercialization, with strong earnings growth certainty, supported by expectations of a stable yuan and a weak US dollar [1] - Southbound funds saw a net purchase of approximately 6.16 billion HKD on February 4, with significant net buying in tech giants like Tencent and Alibaba, and over 8 billion HKD on February 5, indicating a growing interest from mainland investors in Hong Kong tech assets [1]

Core Viewpoint - The biotechnology sector in Hong Kong is experiencing growth potential due to policy support and strong demand, with innovative pharmaceutical companies leading the way in research and development [1] Group 1: Market Performance - On January 7, the Shanghai and Shenzhen markets showed mixed performance with slight fluctuations, while the communication, electronics, and comprehensive sectors led in gains [1] - The Hang Seng Biotechnology ETF (159615.SZ) rose by 2.82%, and Kangfang Biotech increased by 6.56% [1] Group 2: Industry Insights - Huatai Securities highlights that the biotechnology sector benefits from policy backing and has a robust pipeline of innovative drugs and high internationalization [1] - Global investment in biotechnology research and development continues to rise, indicating significant growth potential in sub-sectors like innovative drugs and medical devices [1] Group 3: Valuation and Economic Context - Current valuations of Hong Kong biotechnology companies are considered attractive, with expectations for industry prosperity to increase under supportive policies [1] - The technology sector in Hong Kong has faced valuation pressures due to factors like U.S. Federal Reserve interest rate hikes, but with stabilizing U.S. ten-year Treasury yields, there is an increasing expectation for liquidity improvement and valuation recovery [1] - The positive trend in China's economic recovery and ongoing policy support in the technology sector provide a solid fundamental basis for the Hong Kong technology sector [1] Group 4: Investment Value - The Hang Seng Biotechnology ETF (159615.SZ) serves as a key investment tool for the Hong Kong biotechnology sector, closely tracking the sector and covering areas such as innovative drugs and medical devices, thus presenting good investment value [1]

Core Viewpoint - The Hong Kong stock market, particularly the technology sector, is experiencing a rebound, driven by positive policy signals and liquidity conditions, with a focus on long-term investment opportunities in technology stocks [1][2]. Group 1: Market Performance - The Hang Seng Technology Index rose by 1.1% as of 10:13 AM, with notable gains in automotive stocks and AI hardware/software sectors [1]. - Horizon Robotics-W surged over 7%, while XPeng Motors-W increased by over 4%, and both Li Auto-W and Leap Motor rose by over 2% [1]. - The Hang Seng Technology ETF managed by E Fund has seen a net inflow of approximately 1.5 billion yuan over the past nine trading days [1]. Group 2: Economic Policy and Outlook - China Galaxy Securities indicated that important meetings have set the tone for next year's economic work, emphasizing the continuation of a more proactive fiscal policy and moderately loose monetary policy [1]. - The combination of a loose liquidity environment and favorable policy impacts is expected to support a rebound in the Hong Kong stock market [1]. Group 3: Investment Focus - The technology sector remains a key focus for medium to long-term investments, with valuations having adjusted downwards after previous corrections [1]. - The Hang Seng Technology Index consists of the 30 largest stocks related to technology themes, including major players like Meituan, Tencent, Alibaba, and SMIC [1]. - The current rolling price-to-earnings ratio of the index is 22.9 times, which is below the 30th percentile since its inception in 2020 [1]. Group 4: ETF Details - The E Fund Hang Seng Technology ETF has a latest scale exceeding 26 billion yuan, ranking among the top in its category [2]. - The product has an average daily trading volume of over 1 billion yuan in the past month, indicating good liquidity and support for T+0 trading [2].